FESK.COMYour global study desk
Email us
Home › Scholar › Ton Dang
COMPILEDopen profilenot managed by this scholar
T

Ton Dang

Researcher Profile 6/10
Vietnam Military Medical University · Medicine and Pharmacy
32 publications · 406 citations · h-index 8
This is my profile

Information

An h-index of 8 places this researcher in Medicine and Pharmacy, within the top 25% of 6,619 profiles in this field in our directory.

Featured publications

Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study151 citations
PLoS ONE · 2016 · DOI
A Novel CMKLR1 Small Molecule Antagonist Suppresses CNS Autoimmune Inflammatory Disease77 citations
PLoS ONE · 2014 · DOI
IL-17–Secreting γδ T Cells Are Completely Dependent upon CCR6 for Homing to Inflamed Skin54 citations
The Journal of Immunology · 2017 · DOI
CCR2-Mediated Uptake of Constitutively Produced CCL2: A Mechanism for Regulating Chemokine Levels in the Blood29 citations
The Journal of Immunology · 2019 · DOI
Efficacy of Chemokine Receptor Inhibition in Treating IL-36α–Induced Psoriasiform Inflammation25 citations
The Journal of Immunology · 2019 · DOI
CCR2 antagonism leads to marked reduction in proteinuria and glomerular injury in murine models of focal segmental glomerulosclerosis (FSGS)15 citations
PLoS ONE · 2018 · DOI
Immature dendritic cells expressing indoleamine 2,3-dioxygenase suppress ovalbumin-induced allergic airway inflammation in mice.12 citations
PubMed · 2011
Abstract 5655: Inhibition of CCR2 potentiates checkpoint inhibitor immunotherapy in murine model of pancreatic cancer11 citations
Cancer Research · 2017 · DOI
Correction: Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study7 citations
PLoS ONE · 2019 · DOI
CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity7 citations
PLoS ONE · 2023 · DOI

About the field of Medicine and Pharmacy

6,619researchers 91,896publications 2,589,484citations 4.2average h-index

Common research topics in this field:

Mosquito-borne diseases and controlAntibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyMalaria Research and ControlCOVID-19 and Mental HealthHIV/AIDS Research and Interventions

Institutions with the most researchers in this field:

Hanoi Medical University · 422 University of Medicine and Pharmacy at Ho Chi Minh City · 418 Vietnam National University Ho Chi Minh City · 393 Can Tho University · 311 Hue University · 240

These figures count profiles currently in this directory, not nationwide statistics.

Same institution — Vietnam Military Medical University

P
Pham Van Hien
Chemistry
T
Tho Huu Ho
Biology
N
Nguyen Kim Luu
Medicine and Pharmacy
N
Ngo Sy Thinh
Pharmacy
P
Phong Nguyen Van
Biology
N
Nguyen Minh Hoang
Physics

Same field Medicine and Pharmacy

L
Lê Thái Vân Thanh
University of Medicine and
D
Dung P. Tran
Ho Chi Minh City Universit
T
Trang Huynh
Can Tho University
H
Ha T. Tran
Hanoi Medical University
N
Nguyen Van Dieu
Ho Chi Minh City Universit
H
Ho Anh Hien
Hue University
Verify at: ORCID Find works on Google Scholar ↗ Search Google ↗
The publication list above is compiled from the open academic database OpenAlex (CC0 licence). Compare with the source record on OpenAlex ↗

Suggest / Claim this profile

  
Profile aggregated from public sources. We respect scholars' rights to edit and remove information — all requests are processed promptly.
Ton DangVietnam Military Medical University
Claim
Original profile stored athocthuat.vn— two pages display the same database, verification syncs everywhere.